Status:

WITHDRAWN

Post-marketing Safety Study of GlaxoSmithKline (GSK) Biologicals' Synflorix™ Vaccine, in Healthy Infants and Children in Sri Lanka

Lead Sponsor:

GlaxoSmithKline

Conditions:

Immunisation Against Streptococcus Pneumoniae

Eligibility:

All Genders

6-5 years

Brief Summary

This PMS study aims to collect safety and reactogenicity data of Synflorix™ in healthy infants and children of the local population as per the licensing requirement of the Sri Lankan regulatory author...

Detailed Description

The participating physicians (investigators) will be asked to enrol only those subjects to whom they administer Synflorix™ in the course of their normal clinical practice according to the locally appr...

Eligibility Criteria

Inclusion

  • Subjects who the investigator believes that their parent(s)/ LAR(s) can and will comply with the requirements of the protocol should be enrolled in the PMS study.
  • Infants aged 6 weeks and above and children.
  • Written, signed or thumb-printed informed consent obtained from the parent(s)/LAR(s) of the child. Where subject's parent(s)/LAR(s) are illiterate, the consent form will be countersigned by an impartial witness.
  • Note: Consent for this PMS study is solely for collection of safety and reactogenicity data and not for vaccination that is per routine practice. Data for demography, medical history and previous vaccination history, and concomitant medication/vaccination will also be collected.

Exclusion

  • Subjects with contraindications according to the locally approved PI.
  • Child in care.
  • Previous administration of three doses of Synflorix™.
  • Previous vaccination with a pneumococcal vaccine other than Synflorix™.
  • Planned administration of another pneumococcal vaccine other than Synflorix™ during the PMS study.

Key Trial Info

Start Date :

April 1 2013

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

April 1 2014

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT01803425

Start Date

April 1 2013

End Date

April 1 2014

Last Update

September 9 2013

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

Post-marketing Safety Study of GlaxoSmithKline (GSK) Biologicals' Synflorix™ Vaccine, in Healthy Infants and Children in Sri Lanka | DecenTrialz